Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue 1.4 Market Analysis by Type 1.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Olaparib 1.4.3 Talazoparib 1.5 Market by Application 1.5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2020 VS 2026 1.5.2 Ovarian Cancer 1.5.3 Breast Cancer 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Perspective (2015-2026) 2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Trends by Regions 2.2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Share by Regions (2015-2020) 2.2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Growth Strategy 2.3.6 Primary Interviews with Key PARP (Poly ADP-ribose Polymerase) Inhibitors Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Market Size 3.1.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue (2015-2020) 3.1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Players (2015-2020) 3.1.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio 3.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2019 3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players Head office and Area Served 3.4 Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service 3.5 Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Type (2015-2020) 4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2021-2026) 5 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Application (2015-2026) 5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) 5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020) 6.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in North America (2019-2020) 6.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) 6.4 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) 7 Europe 7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020) 7.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in Europe (2019-2020) 7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) 7.4 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) 8 China 8.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020) 8.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in China (2019-2020) 8.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) 8.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) 9 Japan 9.1 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020) 9.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in Japan (2019-2020) 9.3 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) 9.4 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020) 10.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) 10.4 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) 11 India 11.1 India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020) 11.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in India (2019-2020) 11.3 India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) 11.4 India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020) 12.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in Central & South America (2019-2020) 12.3 Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) 12.4 Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) 13Key Players Profiles 13.1 AbbVie 13.1.1 AbbVie Company Details 13.1.2 AbbVie Business Overview and Its Total Revenue 13.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction 13.1.4 AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)) 13.1.5 AbbVie Recent Development 13.2 Pfizer 13.2.1 Pfizer Company Details 13.2.2 Pfizer Business Overview and Its Total Revenue 13.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction 13.2.4 Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) 13.2.5 Pfizer Recent Development 13.3 AstraZeneca 13.3.1 AstraZeneca Company Details 13.3.2 AstraZeneca Business Overview and Its Total Revenue 13.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction 13.3.4 AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) 13.3.5 AstraZeneca Recent Development 13.4 GlaxoSmithKline 13.4.1 GlaxoSmithKline Company Details 13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction 13.4.4 GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) 13.4.5 GlaxoSmithKline Recent Development 13.5 Clovis Oncology 13.5.1 Clovis Oncology Company Details 13.5.2 Clovis Oncology Business Overview and Its Total Revenue 13.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction 13.5.4 Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) 13.5.5 Clovis Oncology Recent Development 13.6 Everest Pharmaceuticals 13.6.1 Everest Pharmaceuticals Company Details 13.6.2 Everest Pharmaceuticals Business Overview and Its Total Revenue 13.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction 13.6.4 Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) 13.6.5 Everest Pharmaceuticals Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. PARP (Poly ADP-ribose Polymerase) Inhibitors Key Market Segments Table 2. Key Players Covered: Ranking by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Table 3. Ranking of Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Olaparib Table 6. Key Players of Talazoparib Table 7. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions (2015-2020) (US$ Million) Table 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2015-2020) Table 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Growth Strategy Table 17. Main Points Interviewed from Key PARP (Poly ADP-ribose Polymerase) Inhibitors Players Table 18. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Players (2015-2020) (Million US$) Table 19. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players (2015-2020) Table 20. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2019) Table 21. Global PARP (Poly ADP-ribose Polymerase) Inhibitors by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service Table 24. Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$) Table 27. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Type (2015-2020) Table 28. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2021-2026) Table 29. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Application (2015-2020) Table 30. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$) Table 31. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Application (2021-2026) Table 32. North America Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$) Table 33. North America Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020) Table 34. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$) Table 35. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020) Table 36. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$) Table 37. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020) Table 38. Europe Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$) Table 39. Europe Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020) Table 40. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$) Table 41. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020) Table 42. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$) Table 43. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020) Table 44. China Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$) Table 45. China Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020) Table 46. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$) Table 47. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020) Table 48. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$) Table 49. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020) Table 50. Japan Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$) Table 51. Japan Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020) Table 52. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$) Table 53. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020) Table 54. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$) Table 55. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020) Table 58. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020) Table 60. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020) Table 62. India Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$) Table 63. India Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020) Table 64. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$) Table 65. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020) Table 66. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$) Table 67. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020) Table 68. Central & South America Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020) Table 70. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020) Table 72. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020) Table 74. AbbVie Company Details Table 75. AbbVie Business Overview Table 76. AbbVie Product Table 77. AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$) Table 78. AbbVie Recent Development Table 79. Pfizer Company Details Table 80. Pfizer Business Overview Table 81. Pfizer Product Table 82. Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$) Table 83. Pfizer Recent Development Table 84. AstraZeneca Company Details Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Product Table 87. AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$) Table 88. AstraZeneca Recent Development Table 89. GlaxoSmithKline Company Details Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Product Table 92. GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$) Table 93. GlaxoSmithKline Recent Development Table 94. Clovis Oncology Company Details Table 95. Clovis Oncology Business Overview Table 96. Clovis Oncology Product Table 97. Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$) Table 98. Clovis Oncology Recent Development Table 99. Everest Pharmaceuticals Company Details Table 100. Everest Pharmaceuticals Business Overview Table 101. Everest Pharmaceuticals Product Table 102. Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$) Table 103. Everest Pharmaceuticals Recent Development Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type: 2020 VS 2026 Figure 2. Olaparib Features Figure 3. Talazoparib Features Figure 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2020 VS 2026 Figure 5. Ovarian Cancer Case Studies Figure 6. Breast Cancer Case Studies Figure 7. Other Case Studies Figure 8. PARP (Poly ADP-ribose Polymerase) Inhibitors Report Years Considered Figure 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions: 2020 VS 2026 Figure 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players in 2019 Figure 14. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2019 Figure 15. The Top 10 and 5 Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2019 Figure 16. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 23. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. AbbVie Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Pfizer Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) Figure 27. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. AstraZeneca Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) Figure 29. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. GlaxoSmithKline Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) Figure 31. Clovis Oncology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Clovis Oncology Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) Figure 33. Everest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Everest Pharmaceuticals Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) Figure 35. Bottom-up and Top-down Approaches for This Report Figure 36. Data Triangulation Figure 37. Key Executives Interviewed

AbbVie Pfizer AstraZeneca GlaxoSmithKline Clovis Oncology Everest Pharmaceuticals